Aveanna Healthcare (NASDAQ:AVAH) Issues Quarterly Earnings Results

Aveanna Healthcare (NASDAQ:AVAH) posted its earnings results on Thursday. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.05, FiscalAI reports. Aveanna Healthcare had a return on equity of 99.71% and a net margin of 10.56%.The company had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million.

Here are the key takeaways from Aveanna Healthcare’s conference call:

• Q2 revenue rose 13.7% to $670.5 million, while adjusted EBITDA increased 8% to $95.4 million, with year-over-year growth across all three operating segments.
• Aveanna raised 2026 guidance to revenue above $2.68 billion and adjusted EBITDA above $365 million, attributing the increase to core organic performance rather than the recently acquired Family First business.
• The company reported progress on reimbursement and payer initiatives, including seven state rate increases, 37 Private Duty Services preferred payer agreements, and a significant California pediatric nursing rate increase scheduled for January 2027. Aveanna also lifted its long-term organic growth targets for Private Duty Services to 5%–6% and Home Health and Hospice to 8%–10%.
• Management expects gross-margin percentages to remain broadly stable because reimbursement gains will largely be passed through to caregiver wages; it plans to raise California wages ahead of the January 2027 rate increase, creating potential near-term margin pressure. The company also remains highly leveraged, with approximately $1.48 billion of variable-rate debt, despite targeting leverage below 3x over time.

Aveanna Healthcare Price Performance

AVAH stock opened at $12.32 on Friday. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The company has a market capitalization of $2.68 billion, a PE ratio of 10.02, a P/E/G ratio of 1.12 and a beta of 1.90. Aveanna Healthcare has a 12-month low of $5.93 and a 12-month high of $12.52. The business’s fifty day moving average price is $8.97 and its 200 day moving average price is $7.76.

Insider Transactions at Aveanna Healthcare

In related news, major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total transaction of $36,455,577.60. Following the completion of the transaction, the insider directly owned 13,450,547 shares in the company, valued at $83,931,413.28. This trade represents a 30.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of Aveanna Healthcare stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $43,680,000.00. Following the completion of the transaction, the insider directly owned 252,899 shares of the company’s stock, valued at approximately $1,578,089.76. This represents a 96.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 31,305,664 shares of company stock worth $215,555,910 in the last 90 days. Insiders own 5.30% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

Several large investors have recently added to or reduced their stakes in AVAH. AQR Capital Management LLC lifted its holdings in Aveanna Healthcare by 21.2% during the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after buying an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Aveanna Healthcare by 8.3% in the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock worth $1,842,000 after acquiring an additional 25,974 shares in the last quarter. Jane Street Group LLC grew its stake in shares of Aveanna Healthcare by 522.0% in the first quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock worth $407,000 after acquiring an additional 63,010 shares in the last quarter. Creative Planning increased its position in shares of Aveanna Healthcare by 15.1% during the second quarter. Creative Planning now owns 47,025 shares of the company’s stock worth $246,000 after acquiring an additional 6,171 shares during the period. Finally, JPMorgan Chase & Co. increased its position in shares of Aveanna Healthcare by 65.0% during the second quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock worth $828,000 after acquiring an additional 62,348 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

AVAH has been the subject of a number of recent analyst reports. Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Truist Financial upped their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. UBS Group increased their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $11.78.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations. Revenue increased 13.7% year over year to $670.5 million, while net income rose to $40.3 million from $27.0 million. Adjusted EBITDA reached $95.4 million, up 8.0%, and adjusted EPS of $0.22 topped analyst estimates of $0.19. Aveanna Healthcare Second Quarter Financial Results and Revised 2026 Guidance
• Positive Sentiment: Management raised full-year guidance. Aveanna now expects 2026 revenue above $2.68 billion, compared with its previous $2.63 billion-$2.65 billion range, and adjusted EBITDA above $365 million, up from $338 million-$342 million. The company cited reimbursement improvements, preferred-payer relationships and continued demand for complex home care. AVAH Q2 Earnings Call Highlights Higher Growth Targets
• Positive Sentiment: Analysts lifted their price targets. BMO Capital Markets raised its target from $10 to $14 and maintained an “outperform” rating. UBS raised its target from $8 to $13, although it retained a “neutral” rating. The revisions signal improved earnings expectations and support the stock’s recent strength. Benzinga analyst price target updates
• Neutral Sentiment: Growth is concentrated in Private Duty Services, which generates roughly 83% of revenue. Rapid revenue expansion is offsetting pressure on gross margins across business segments, making margin trends an important focus for investors. Aveanna Healthcare Q2 Earnings Report

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.